Union Minister Jitendra Singh inaugurated a new biotechnology facility and dedicated a national facility for recombinant cells and sensors at the Rajiv Gandhi Centre for Biotechnology in Thiruvananthapuram, highlighting India's focus on biotechnology and its potential for economic growth.
Prime Minister Narendra Modi urged CEOs of US majors to take advantage of India's growth story as the country is making all efforts to become the third largest economy of the world in his third term. India is currently the fifth largest economy of the world after the US, China, Germany and Japan with a GDP of around $3.9 trillion. India has been the fastest growing large economies of the world with GDP growth rate of over 7 per cent for the last three consecutive years.
India's ambitious programme to cut oil import bill by mixing a small percentage of non-edible oil in diesel has encountered an unexpected problem.
India's well-known investors who are known for their Midas touch have spotted an opportunity in bio-fuel, betting big on ethanol, bio-mass and even bio-fuel equipment makers in India and other parts of the globe.
The national selection committee, led by Chetan Sharma, is fretting over inclusion of an additional fast bowler in India's T20 World Cup squad as Hardik Pandya's chances of bowling during the tournament look bleak.
'We're excited about Rohit coming back. Spoke to him yesterday, he's waiting to join the team.'
With Royal Challengers Bangalore losing to Sunrisers Hyderabad in the IPL Eliminator match on Friday, India captain Virat Kohli moved into the bio-bubble created for the Indian players as they prepare for the upcoming tour of Australia.
Australia leg-spinner Adam Zampa says he decided to quit the IPL midway as it was the "most vulnerable" bio-bubble he was part of.
Biotechnology major Biocon on Tuesday said it aims to achieve revenues of $1 billion in the next three years.
Novartis India invites students to participate in the 2nd Biotechnology Leadership Camp (BioCamp) taking place in Hyderabad from July1 to 3, 2010.
The judgment could impact not only Ramdev's widespread ayurveda and herbal products business, but also that of many other pharmaceutical, ayurveda, herbal and cosmetic product manufacturers.
Top executives of American pharma companies favour "dialogue" with India and "not confrontation" to address their concerns on key issues like the protection of intellectual property (IP) and clinical trials.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances